Search Results - Chuanjie Wu

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    A multicenter single‐arm objective performance criteria trial evaluating the efficacy and safety of a dedicated venous sinus thrombectomy device for severe cerebral venous sinus th... by Shadamu Yusuying, Yan Wu, Ming Li, Jiangang Duan, Jian Chen, Yujiao Chen, Chen Zhou, Hetao Bian, Chuanhui Li, Chuanjie Wu, Ran Meng, Xunming Ji

    Published 2024-12-01

    Abstract Aim Approximately 21% of patients with cerebral venous sinus thrombosis (CVST) are refractory to anticoagulation treatment and face poor prognosis. These patients may benefit from endovascular therapy. Although numerous studies have reported promising results with endovascular therapy, it r...

    Full description

    Get full text
    Article
  2. 2

    Albumin for patients with acute large-vessel occlusive stroke undergoing endovascular therapy (ARISE): the protocol of a randomized double-blind trial by Yuanyuan Liu, Xiao Dong, Xuehong Chu, Zhengfei Ma, Tingyu Yi, Tingyu Yi, Changming Wen, Yifeng Liu, Jun Sun, Jing Xu, Wenbo Li, Lei Yang, Benxiao Wang, Lei Shi, Jianqiao Li, Xiaoman Zhang, Chaoqun Li, Wenhuo Chen, Chuanhui Li, Di Wu, Chengbei Hou, Chen Zhou, Ming Li, Ming Li, Yi Xu, Chuanjie Wu, Xunming Ji, Xunming Ji

    Published 2025-07-01

    BackgroundAlbumin is a multifunctional plasma protein that is mainly synthesized in the liver and may play a neuroprotective role in treating acute ischemic stroke (AIS). The efficacy of albumin in patients with AIS receiving reperfusion therapy remains unknown.MethodsARISE is a multicenter, randomi...

    Full description

    Get full text
    Article